Skip to main content

Table 1 Baseline characteristics of patients

From: Safety, tolerability and immunogenicity of V934/V935 hTERT vaccination in cancer patients with selected solid tumors: a phase I study

Characteristics

Total

n

%

Patients in population

37

100

Gender

 Male

27

73.0

 Female

10

27.0

Age (years)

 Patients with data

37

 

 Mean

62.4

 

 SD

11.0

 

 Median

61.0

 

 Range

36–83

 

Racial origin

 White

35

94.6

 Black

2

5.4

Baseline ECOG

 0

36

97.3

 1

1

2.7

Primary malignancies

 Bladder carcinoma

1

2.7

 Breast cancer

3

8.1

 Gastroesophageal junction

1

2.7

 Malignant melanoma

3

8.1

 Melanoma

5

13.5

 Non-small-cell lung cancer

8

21.6

 Pancreatic carcinoma

1

2.7

 Prostate cancer

14

37.8

 Renal cell carcinoma

1

2.7

  1. Subjects with missing baseline information are excluded from the corresponding analysis
  2. SD standard deviation